[New hormonal treatments of metastatic prostatic cancer. Review of the literature].
D000616:Aminoglutethimide / Q000627:therapeutic use; D000726:Androgen Antagonists / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004351:Drug Resistance; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000627:therapeutic use; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D007654:Ketoconazole / Q000627:therapeutic use; D008297:Male; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000601:surgery / Q000628:therapy; D013997:Time Factors
D000726:Androgen Antagonists; D000970:Antineoplastic Agents; D006728:Hormones; D000616:Aminoglutethimide; D007987:Gonadotropin-Releasing Hormone; D007654:Ketoconazole
Les nouveaux traitements hormonaux du cancer prostatique métastasé. Revue de la littérature.